William Blair Investment Management LLC Acquires 35,820 Shares of Cabot Corporation $CBT

William Blair Investment Management LLC boosted its holdings in shares of Cabot Corporation (NYSE:CBT – Free Report) by 19.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 220,897 shares of the specialty chemicals company’s stock after buying an additional 35,820 shares during the quarter. William Blair Investment Management LLC owned approximately 0.43% of Cabot worth $16,989,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Eurizon Capital SGR S.p.A. bought a new stake in shares of Cabot during the 3rd quarter valued at $229,000. Ritholtz Wealth Management purchased a new stake in shares of Cabot in the 3rd quarter worth $307,000. Hohimer Wealth Management LLC increased its stake in shares of Cabot by 6.3% in the 3rd quarter. Hohimer Wealth Management LLC now owns 2,944 shares of the specialty chemicals company’s stock worth $226,000 after purchasing an additional 174 shares in the last quarter. Parallel Advisors LLC raised its holdings in Cabot by 7.6% in the 3rd quarter. Parallel Advisors LLC now owns 2,484 shares of the specialty chemicals company’s stock worth $191,000 after purchasing an additional 176 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in Cabot in the 3rd quarter worth $481,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on CBT shares. Wall Street Zen downgraded Cabot from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Weiss Ratings cut Cabot from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday. UBS Group decreased their price objective on Cabot from $86.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 4th. Zacks Research cut Cabot from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 5th. Finally, Truist Financial lowered their price objective on Cabot from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Cabot presently has an average rating of “Hold” and an average price target of $83.60.

Get Our Latest Analysis on CBT

Insider Activity at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.08% of the stock is owned by insiders.

Cabot Stock Up 0.1%

CBT opened at $71.99 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.44 and a current ratio of 2.16. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The firm’s fifty day moving average is $75.86 and its 200 day moving average is $79.54. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 17.95, a price-to-earnings-growth ratio of 9.11 and a beta of 0.83.

Cabot (NYSE:CBT – Get Free Report) last issued its earnings results on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.06. Cabot had a net margin of 5.69% and a return on equity of 19.64%. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $927.29 million. During the same quarter in the prior year, the firm posted $1.70 EPS. Cabot’s quarterly revenue was up 12.2% compared to the same quarter last year. On average, sell-side analysts forecast that Cabot Corporation will post 6.58 earnings per share for the current fiscal year.

Cabot Profile

(Free Report)

Cabot Corporation is a specialty chemicals and performance materials company that develops and manufactures materials used in products across transportation, energy, infrastructure, electronics and consumer markets. Its offerings include reinforcing carbon blacks for tires and other rubber products, specialty carbons and battery materials, fumed silica and other specialty compounds. Founded in 1882, Cabot has expanded from its early carbon black business into a broader portfolio of performance materials.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.